← 返回

通过跷跷板运动生物反应器中的机械刺激规模化生产源自 NK 细胞的细胞外囊泡用于癌症治疗

英文原题:Scale-out production of extracellular vesicles derived from natural killer cells via mechanical stimulation in a seesaw-motion bioreactor for cancer therapy.

查看英文原题

Scale-out production of extracellular vesicles derived from natural killer cells via mechanical stimulation in a seesaw-motion bioreactor for cancer therapy.

PubMed 2022/08/05(内容时间) Biofabrication Q1 · IF 8.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

来自免疫细胞的细胞外囊泡(EVs)已显示出巨大的抗癌治疗潜力。然而,EV生成效率低下极大地阻碍了基于EV的基础研究和临床转化的发展。

在此,我们利用剪切应力和湍流等机械刺激,开发了一种跷跷板运动生物反应器(SMB)系统,用于从自然杀伤(NK)细胞中高质量、高产量地生成EVs。与传统静态培养中的EV产量(每细胞每天229 ± 74个颗粒)相比,SMB以每细胞每天438 ± 50个颗粒的更高产率产生NK-92MI来源的EVs,并通过连续动态流体培养在两周内总共产出2 × 10 11个EVs。

此外,在SMB中从NK-92MI细胞生成的EVs与传统静态培养生成的EVs具有相似的形态、粒径分布和蛋白质谱。最重要的是,SMB中NK-92MI来源的EVs在体外2D和3D培养条件下均具有杀伤黑色素瘤和肝癌细胞的功能活性,并且在体内也能抑制黑色素瘤生长。

我们认为,SMB是一种有吸引力的高质量、高产量生产EVs的方法;它还能增强NK92-MI细胞的EV生产,并促进EVs的基础和转化研究。

展开英文摘要原文

Extracellular vesicles (EVs) derived from immune cells have shown great anti-cancer therapeutic potential.

However, inefficiency in EV generation has considerably impeded the development of EV-based basic research and clinical translation.

Here, we developed a seesaw-motion bioreactor (SMB) system by leveraging mechanical stimuli such as shear stress and turbulence for generating EVs with high quality and quantity from natural killer (NK) cells. Compared to EV production in traditional static culture (229 ± 74 particles per cell per day), SMB produced NK-92MI-derived EVs at a higher rate of 438 ± 50 particles per cell per day and yielded a total number of 2 × 10 11 EVs over two weeks via continuous dynamic fluidic culture.

In addition, the EVs generated from NK-92MI cells in SMB shared a similar morphology, size distribution, and protein profile to EVs generated from traditional static culture. Most importantly, the NK-92MI-derived EVs in SMB were functionally active in killing melanoma and liver cancer cells in both 2D and 3D culture conditions in vitro , as well as in suppressing melanoma growth in vivo .

We believe that SMB is an attractive approach to producing EVs with high quality and quantity; it can additionally enhance EV production from NK92-MI cells and promote both the basic and translational research of EVs.

论文信息

作者
Wu J、Wu D、Wu G、Bei HP、Li Z、Xu H、Wang Y、Wu D
单位
Department of Respiratory and Critical Care Medicine, Provincial Clinical Research Center for Respiratory Diseases, West China Hospital, Sichuan University, Chengdu 610065, People's Republic of China.China
文献类型
非美国政府资助研究
期刊
Biofabrication2022 Aug 5
原文标识
PubMed 35793612 · DOI 10.1088/1758-5090/ac7eeb